Answers are grounded in this paper and cite their sources.
To determine if there is a gene variant of protein serine-threonine phosphatase with EF hand (PPEF-1) in T-cell lymphoblastic lymphoma SUP-T1 cell line, both in silico and in vitro approaches were conducted. In silico, a cDNA clone showing similar sequence to PPEF-1 was isolated from the SUP-T1 cDNA library and named PPEF-1V. The full-length of the PPEF-1V cDNA clone is a 2135bp containing a 1503bp open reading frame extending from 188bp to 1690bp, which corresponds to an encoded protein of 501 amino acid residues with a predicted molecular mass of 57.8 kDa. Alignment on both PPEF-1V and PPEF-1 sequences showed that PPEF-1V is a 350bp deletion in the nucleotide sequence of PPEF-1 from 128-477bp and a 152-amino-acid N-terminal deletion in the amino acid sequence of PPEF-1. In vitro, PPEF-1V transcript fragment was only highly expressed in T-cell lymphoblastic lymphoma cell line. In conclusion, the present patent showed that PPEF-1V could be a potential target for diagnosis or treatment of T-cell lymphoblastic lymphoma. Keywords: Protein serine-threonine phosphatase with EF hand, T-cell lymphoblastic lymphoma, n serine-threonine phosphatase with EF hand, PPEF-1, gene variant, lymphoblastic lymphoma, cancer, RT-PCR Expression, cDNA Clones, Nucleotide Sequencing, PPEF-1V cDNA, PROSITE, RT-PCR, T-cell lymphomas, Expressed sequence tags, XLOLR cells, NHL
No takes yet. Share an insight, caveat, or question.
Ho et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: